CC · The Chemours Company

Chemours reported mixed Q1 2026 results. Net sales of $1.4 billion increased 1% year-over-year, driven by a record quarter in Thermal & Specialized Solutions (TSS), which saw 22% sales growth to $568 million, fueled by strong Opteon™ and Freon™ refrigerant demand. However, Titanium Technologies (TT) sales fell 6% to $559 million on lower volumes, and Advanced Performance Materials (APM) declined 17% to $243 million due to a plant outage at Washington Works. Net loss attributable to Chemours widened to $29 million from $5 million in the prior year, impacted by higher financing costs from a recent debt offering and increased SG&A. Adjusted EBITDA rose 2% to $169 million, with TSS Adjusted EBITDA up 35% to $190 million and margin expanding to 33%, while TT Adjusted EBITDA plunged 64% to $18 million and APM fell 84% to $5 million. Management highlighted strong execution in TSS and TT, and the receipt of ~$287 million from the Kuan Yin site sale used to pay down €140 million of debt. For Q2 2026, the company expects net sales to increase 15-20% sequentially and Adjusted EBITDA of $220-250 million, with TSS benefiting from seasonal cooling demand and TT from pricing actions. Full-year 2026 outlook remains unchanged: net sales growth of 3-5% and Adjusted EBITDA of $800-900 million.